IMNM
Immunome Inc
22.30$
-7.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +59.4% | +115.3% | -7.4% | -13.3% | -6.5% | +42.6% | -13.5% | +1.0% | +128.2% | -9.3% | -8.8% | |
| – | +58.3% | +116.5% | -9.3% | -14.2% | -9.3% | +46.0% | -14.1% | +0.9% | +136.1% | -10.1% | -9.4% | |
| – | +8.9% | +173.3% | -38.7% | -5.9% | -7.9% | +79.7% | -44.2% | +89.5% | +139.7% | -10.8% | -62.6% | |
| – | +52.4% | +124.2% | -10.1% | -13.7% | -9.5% | +46.0% | -15.5% | +1.7% | +139.7% | -10.8% | -10.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -67.1% | +19.3% | +24.0% | -0.9% | +40.7% | -39.8% | -24.0% | +31.2% | +37.8% | -36.3% | +29.6% | |
| – | -5.5% | +41.0% | +29.7% | -0.9% | +37.4% | -43.3% | -25.7% | +37.4% | +43.1% | -39.1% | +30.3% | |
| – | +24.5% | +35.2% | -29.6% | -12.9% | -75.5% | – | – | – | – | – | – | |
| – | +18.8% | +116.8% | -1.8% | -50.1% | +303.3% | -35.7% | -48.9% | +31.9% | -45.7% | +65.7% | +8.3% | |
| – | +1,873.0% | +138.2% | -11.1% | -15.3% | -15.7% | +69.5% | -12.3% | -2.0% | +140.4% | -7.2% | -10.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +79.9% | -53.0% | +481.4% | +0.4% | +4.2% | +26.6% | +9.6% | +1.1% | -0.7% | +29.5% | +0.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.